Jane Street’s Crescent Biopharma CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,965
Closed -$272K 12196
2025
Q4
$272K Buy
+22,965
New +$293K ﹤0.01% 9057
2025
Q1
Sell
-589
Closed -$14.7K 9868
2024
Q4
$14.7K Buy
+589
New +$16.1K ﹤0.01% 9157
2024
Q3
Sell
-297
Closed -$8.36K 9885
2024
Q2
$8.36K Sell
297
-2,596
-90% -$270K ﹤0.01% 9127
2024
Q1
$868K Buy
2,893
+2,322
+407% +$694K ﹤0.01% 5672
2023
Q4
$135K Buy
571
+371
+186% +$57.7K ﹤0.01% 8445
2023
Q3
$29.9K Buy
+200
New +$31.6K ﹤0.01% 8249
2023
Q2
Sell
-267
Closed -$33.7K 9013
2023
Q1
$33.7K Buy
267
+19
+8% +$4.28K ﹤0.01% 8546
2022
Q4
$75.1K Buy
+248
New +$36.6K ﹤0.01% 8234
2022
Q3
Sell
-192
Closed -$11K 9992
2022
Q2
$11K Buy
+192
New +$14.2K ﹤0.01% 9288
2021
Q3
Sell
-386
Closed -$90K 10259
2021
Q2
$90K Buy
386
+271
+236% +$69K ﹤0.01% 9308
2021
Q1
$35K Buy
+115
New +$41.2K ﹤0.01% 8898
2020
Q2
Sell
-162
Closed -$37K 7280
2020
Q1
$37K Buy
+162
New +$61.9K ﹤0.01% 5122
2019
Q1
Sell
-121
Closed -$114K 5245
2018
Q4
$114K Buy
+121
New +$146K ﹤0.01% 4604

Other funds holding CBIO